FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385697607> ?p ?o ?g. }

• W4385697607 endingPage "2108" @default.
• W4385697607 startingPage "2108" @default.
• W4385697607 abstract "Anti-angiogenic RNAi-based therapy can be considered as a possible strategy for the treatment of endometriosis (EM), which is the most common gynecological disease. Targeted delivery of siRNA therapeutics is a prerequisite for successful treatment without adverse effects. Here we evaluated the RGD1-R6 peptide carrier as a non-viral vehicle for targeted siRNA delivery to endothelial cells in vitro and endometrial implants in vivo. The physicochemical properties of the siRNA complexes, cellular toxicity, and GFP and VEGFA gene silencing efficiency were studied, and anti-angiogenic effects were proved in cellular and animal models. The modification of siRNA complexes with iRGD ligand resulted in a two-fold increase in gene knockdown efficiency and three-fold decrease in endothelial cells’ migration in vitro. Modeling of EM in rats with the autotransplantation of endometrial tissue subcutaneously was carried out. Efficiency of anti-angiogenic EM therapy in vivo by anti-VEGF siRNA/RGD1-R6 complexes was evaluated by the implants’ volume measurement, CD34 immunohistochemical staining, and VEGFA gene expression analysis. We observed a two-fold decrease in endometriotic implants growth and a two-fold decrease in VEGFA gene expression in comparison with saline-treated implants. RNAi-mediated therapeutic effects were comparable with Dienogest treatment efficiency in a rat EM model. Taken together, these findings demonstrate the advantages of RGD1-R6 peptide carrier as a delivery system for RNAi-based therapy of EM." @default.
• W4385697607 created "2023-08-10" @default.
• W4385697607 creator A5021726242 @default.
• W4385697607 creator A5042808178 @default.
• W4385697607 creator A5046292096 @default.
• W4385697607 creator A5070828812 @default.
• W4385697607 creator A5083053695 @default.
• W4385697607 creator A5087901143 @default.
• W4385697607 creator A5092618193 @default.
• W4385697607 date "2023-08-09" @default.
• W4385697607 modified "2023-09-30" @default.
• W4385697607 title "iRGD-Targeted Peptide Nanoparticles for Anti-Angiogenic RNAi-Based Therapy of Endometriosis" @default.
• W4385697607 cites W126428498 @default.
• W4385697607 cites W1647075334 @default.
• W4385697607 cites W1825884631 @default.
• W4385697607 cites W1971509660 @default.
• W4385697607 cites W1985959551 @default.
• W4385697607 cites W2005858784 @default.
• W4385697607 cites W2015007786 @default.
• W4385697607 cites W2018304270 @default.
• W4385697607 cites W2037277061 @default.
• W4385697607 cites W2037548392 @default.
• W4385697607 cites W2061289968 @default.
• W4385697607 cites W2062713415 @default.
• W4385697607 cites W2063749440 @default.
• W4385697607 cites W2069967994 @default.
• W4385697607 cites W2071235278 @default.
• W4385697607 cites W2071667212 @default.
• W4385697607 cites W2078080940 @default.
• W4385697607 cites W2080753275 @default.
• W4385697607 cites W2086233980 @default.
• W4385697607 cites W2099113192 @default.
• W4385697607 cites W2110652303 @default.
• W4385697607 cites W2112885348 @default.
• W4385697607 cites W2125291595 @default.
• W4385697607 cites W2132467763 @default.
• W4385697607 cites W2132946391 @default.
• W4385697607 cites W2137191456 @default.
• W4385697607 cites W2144276846 @default.
• W4385697607 cites W2146205715 @default.
• W4385697607 cites W2151386917 @default.
• W4385697607 cites W2323551785 @default.
• W4385697607 cites W2333901123 @default.
• W4385697607 cites W2462762080 @default.
• W4385697607 cites W2535884567 @default.
• W4385697607 cites W2581462166 @default.
• W4385697607 cites W2767225262 @default.
• W4385697607 cites W2793538920 @default.
• W4385697607 cites W2894408736 @default.
• W4385697607 cites W2948027412 @default.
• W4385697607 cites W2955459703 @default.
• W4385697607 cites W2982610165 @default.
• W4385697607 cites W2992823069 @default.
• W4385697607 cites W3005100376 @default.
• W4385697607 cites W3010977327 @default.
• W4385697607 cites W3092316817 @default.
• W4385697607 cites W3123286810 @default.
• W4385697607 cites W3127986614 @default.
• W4385697607 cites W3205101530 @default.
• W4385697607 cites W4200109962 @default.
• W4385697607 cites W4210574849 @default.
• W4385697607 cites W4283745618 @default.
• W4385697607 cites W4301600652 @default.
• W4385697607 cites W4365810819 @default.
• W4385697607 doi "https://doi.org/10.3390/pharmaceutics15082108" @default.
• W4385697607 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37631322" @default.
• W4385697607 hasPublicationYear "2023" @default.
• W4385697607 type Work @default.
• W4385697607 citedByCount "0" @default.
• W4385697607 crossrefType "journal-article" @default.
• W4385697607 hasAuthorship W4385697607A5021726242 @default.
• W4385697607 hasAuthorship W4385697607A5042808178 @default.
• W4385697607 hasAuthorship W4385697607A5046292096 @default.
• W4385697607 hasAuthorship W4385697607A5070828812 @default.
• W4385697607 hasAuthorship W4385697607A5083053695 @default.
• W4385697607 hasAuthorship W4385697607A5087901143 @default.
• W4385697607 hasAuthorship W4385697607A5092618193 @default.
• W4385697607 hasBestOaLocation W43856976071 @default.
• W4385697607 hasConcept C104317684 @default.
• W4385697607 hasConcept C111599444 @default.
• W4385697607 hasConcept C119056186 @default.
• W4385697607 hasConcept C135983454 @default.
• W4385697607 hasConcept C146285616 @default.
• W4385697607 hasConcept C150903083 @default.
• W4385697607 hasConcept C166703698 @default.
• W4385697607 hasConcept C167734588 @default.
• W4385697607 hasConcept C173396325 @default.
• W4385697607 hasConcept C185592680 @default.
• W4385697607 hasConcept C207001950 @default.
• W4385697607 hasConcept C2777025900 @default.
• W4385697607 hasConcept C502942594 @default.
• W4385697607 hasConcept C55493867 @default.
• W4385697607 hasConcept C67705224 @default.
• W4385697607 hasConcept C71924100 @default.
• W4385697607 hasConcept C86803240 @default.
• W4385697607 hasConceptScore W4385697607C104317684 @default.
• W4385697607 hasConceptScore W4385697607C111599444 @default.
• W4385697607 hasConceptScore W4385697607C119056186 @default.

• next